Evaluation of the appropriate use of albumin in adult and pediatric patients

American Journal of Health-System Pharmacy

Volumn 60, Issue 13, 2003, Pages 1330-1335

  Tanzi, Mario ^a,c   Gardner, Melinda ^a   Megellas, Michelle ^a   Lucio, Steven ^a   Restino, Maryann ^b  

^a Pharmacy Clinical Solutions   (United States)

^b Contract and Program Services ^*

^c Novation   (United States)

Author keywords

Albumin; Drug use; Pediatrics; Prescribing; Proteins; Rational therapy

Indexed keywords

ALBUMIN; SERUM ALBUMIN;

ADOLESCENT; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; BLOOD PRESSURE REGULATION; CHILD; CHILD CARE; COLLOID; CONTROLLED STUDY; DRUG USE; HOSPITAL CARE; HUMAN; HYPOTENSION; HYPOVOLEMIA; MAJOR CLINICAL STUDY; PARACENTESIS; PATIENT CARE; PHARMACEUTICAL CARE; PRESCRIPTION; PRIORITY JOURNAL; SHOCK; TREATMENT INDICATION; TREATMENT PLANNING; AGED; CLINICAL PRACTICE; CLINICAL TRIAL; FEMALE; MALE; MIDDLE AGED; MULTICENTER STUDY; PRACTICE GUIDELINE; PRESCHOOL CHILD; STATISTICS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DRUG UTILIZATION REVIEW; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; SERUM ALBUMIN;

EID: 0242273292     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/60.13.1330     Document Type: Article

References (17)

1. Ratner LE, Smith GW. Intraoperative fluid management. Surg Clin North Am. 1993; 73:229-41.
2. Bisonni RS, Holtgrave DR, Lawler F et al. Colloids versus crystalloids in fluid resuscitation: an analysis of randomized controlled trials. J Fam Pract. 1991; 32:387-90.
3. Tranbaugh RF, Lewis FR. Crystalloid versus colloid for fluid resuscitation of hypovolemic patients. Adv Shock Res. 1983; 9:203-16.
4. Wagner BK, D'Amelio LF. Pharmacologic and clinical considerations in selecting crystalloid, colloid, and oxygen-carrying resuscitation fluids, part I. Clin Pharm. 1993; 12:335-46.
5. Wagner BK, D'Amelio LF. Pharmacologic and clinical considerations in selecting crystalloid, colloid, and oxygen-carrying resuscitation fluids, part 2. Clin Pharm. 1993; 12:415-28.
6. Schierhout G, Roberts I. Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials. BMJ. 1998; 316:961-4.
7. Colgan K, Moody ML, Witte K. Responsible use of blood products in response to supply and demand. Am J Health-Syst Pharm. 2000; 57:2094-8.
8. Galardi DA, Herson N. Pricing of blood products. Am J Health-Syst Pharm. 2000; 57:2061. Editorial.
9. Grabenstein JD. The safety and hazards of blood-derived drugs. Am J Health-Syst Pharm. 1995; 52:2448-52.
10. Food and Drug Administration. Recall of albumin (human) 5%, Albuminar-5. www.fda.gov/cber/recalls/avealb072001.htm (accessed 2002 May 8).
11. Food and Drug Administration. Recall of albumin (human) 5%, Buminate 5%. www.fda.gov/cber/recalls/baxalb071801.htm (accessed 2002 May 8).
12. Debrix I, Combeau D, Stephan F et al. Clinical practice guidelines for the use of albumin: results of a drug use evaluation in a Paris hospital. Pharm World Sci. 1999; 21:11-6.
13. Vermeulen LC, Ratko TA, Erstad BL et al. A paradigm for consensus. The University Hospital Consortium guidelines for the use of albumin, nonprotein colloid, and crystalloid solutions. Arch Intern Med. 1995; 155:373-9.
14. Yim JM, Vermeulen LC, Erstad BL et al. Albumin and nonprotein colloid solution use in US academic health centers. Arch Intern Med. 1995; 155:2450-5.
15. Groeneveld AB. Albumin and artificial colloids in fluid management: where does the clinical evidence of their utility stand? Crit Care. 2000; 4(suppl 2):S16-20.
16. Bunn F, Alderson P, Hawkins V. Colloid solutions for fluid resuscitation (Cochrane Review). In The Cochrane Library, Issue 2, 2002. Oxford: Update Software. CD-ROM.
17. Technology assessment: albumin, non-protein colloid, and crystalloid solutions. Oak Brook, IL: University HealthSystem Consortium; 2000.